Journal Menu
► ▼ Journal Menu-
- Hemato Home
- Aims & Scope
- Editorial Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Most Cited & Viewed
Most Cited & Viewed Papers
Citations | Article |
---|---|
Integrative Statistics, Machine Learning and Artificial Intelligence Neural Network Analysis Correlated CSF1R with the Prognosis of Diffuse Large B-Cell Lymphoma
by
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Giovanna Roncador, Juan Fernando Garcia, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Atsushi Ito, Yoshihiro Komohara, Naoya Nakamura and Rifat Hamoudi
|
|
Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
by
Gareth J. Morgan, Joel N. Buxbaum and Jeffery W. Kelly
|
|
Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania
by
Manase Kilonzi, Hamu J. Mlyuka, Fatuma Felix Felician, Dorkasi L. Mwakawanga, Lulu Chirande, David T. Myemba, Godfrey Sambayi, Ritah F. Mutagonda, Wigilya P. Mikomangwa, Joyce Ndunguru, Agnes Jonathan, Paschal Ruggajo, Irene Kida Minja, Emmanuel Balandya, Julie Makani and Nathanael Sirili
|
|
Burkitt Lymphoma Incidence in Five Continents
by
Sam M. Mbulaiteye and Susan S. Devesa
|
|
Sickle Cell Disease, a Review
by
Cameron K. Tebbi
|
|
SARS-CoV-2 and Autoimmune Cytopenia
by
Ryann Quinn and Irina Murakhovskaya
|
|
Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
by
Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka and Josephine M. I. Vos
|
|
CAR-T Cell Therapy for the Treatment of ALL: Eradication Conditions and In Silico Experimentation
by
Paul A. Valle, Luis N. Coria, Corina Plata and Yolocuauhtli Salazar
|
|
Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis
by
Francesca Lavatelli
|
|
Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features
by
Marco Lucioni, Sara Fraticelli, Giuseppe Neri, Monica Feltri, Giuseppina Ferrario, Roberta Riboni and Marco Paulli
|
Citations | Article |
---|---|
The Role of Platelet Molecules in Risk Stratification of Patients with COVID-19
by
Lívia de Oliveira Sales, Lais Lacerda Brasil de Oliveira, Jean Breno Silveira da Silva, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro and Caroline Aquino Moreira-Nunes
|
|
Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia
by
Francisco Alejandro Lagunas-Rangel and Venice Chávez-Valencia
|
Citations | Article |
---|---|
Integrative Statistics, Machine Learning and Artificial Intelligence Neural Network Analysis Correlated CSF1R with the Prognosis of Diffuse Large B-Cell Lymphoma
by
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Giovanna Roncador, Juan Fernando Garcia, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Atsushi Ito, Yoshihiro Komohara, Naoya Nakamura and Rifat Hamoudi
|
|
Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
by
Gareth J. Morgan, Joel N. Buxbaum and Jeffery W. Kelly
|
|
Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania
by
Manase Kilonzi, Hamu J. Mlyuka, Fatuma Felix Felician, Dorkasi L. Mwakawanga, Lulu Chirande, David T. Myemba, Godfrey Sambayi, Ritah F. Mutagonda, Wigilya P. Mikomangwa, Joyce Ndunguru, Agnes Jonathan, Paschal Ruggajo, Irene Kida Minja, Emmanuel Balandya, Julie Makani and Nathanael Sirili
|
|
Burkitt Lymphoma Incidence in Five Continents
by
Sam M. Mbulaiteye and Susan S. Devesa
|
|
Sickle Cell Disease, a Review
by
Cameron K. Tebbi
|
|
SARS-CoV-2 and Autoimmune Cytopenia
by
Ryann Quinn and Irina Murakhovskaya
|
|
Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
by
Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka and Josephine M. I. Vos
|
|
CAR-T Cell Therapy for the Treatment of ALL: Eradication Conditions and In Silico Experimentation
by
Paul A. Valle, Luis N. Coria, Corina Plata and Yolocuauhtli Salazar
|
|
Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis
by
Francesca Lavatelli
|
|
Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features
by
Marco Lucioni, Sara Fraticelli, Giuseppe Neri, Monica Feltri, Giuseppina Ferrario, Roberta Riboni and Marco Paulli
|
Views | Article |
---|---|
Methotrexate-Induced Subacute Combined Degeneration in Acute Lymphoblastic Leukemia with CNS Relapse May Be Reversible
by
David Bared Dukenik, Deborah Soong, Wenhui Li, Ellen Madarang, Justin Watts and Justin Taylor
|
|
Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance
by
Karina P. Verma, Rebecca Steuer and Camille V. Edwards
|
|
Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations
by
Aditi Sharma, Amit Dahiya, Asif Alavi, Indryas Woldie, Aditya Sharma, Jeffrey Karson and Vijendra Singh
|
|
Parenteral Iron Therapy for Pediatric Patients
by
Elpis Mantadakis, Sonia Alexiadou and Panagiota Zikidou
|
|
Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia
by
Francisco Alejandro Lagunas-Rangel and Venice Chávez-Valencia
|
|
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis
by
Chiara Marvisi, Elena Galli, Caterina Ricordi, Rexhep Durmo, Massimo Roncali, Francesco Muratore, Carlo Salvarani and Annibale Versari
|
|
The Role of Platelet Molecules in Risk Stratification of Patients with COVID-19
by
Lívia de Oliveira Sales, Lais Lacerda Brasil de Oliveira, Jean Breno Silveira da Silva, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro and Caroline Aquino Moreira-Nunes
|
|
Coagulation Profiles in Humans Exposed to Exertional Hypobaric Decompression Stress Determined by Calibrated Automated Thrombogram
by
Leigh A. Madden, Rebecca V. Vince, Victoria C. Edwards, Vivienne M. Lee and Desmond M. Connolly
|
|
Demyelinating Polyradiculoneuropathy in Chronic Lymphocytic Leukemia: A Case Report on BTKis versus Venetoclax-Rituximab
by
Alessandro Cellini, Andrea Visentin, Alessandro Salvalaggio, Mario Cacciavillani, Sergio Ferrari and Chiara Briani
|
|
Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis
by
Michael Dennis Weaver, Bianca Glass, Chance Aplanalp, Gauri Patel, Jeshrine Mazhil, Isabella Wang and Samir Dalia
|
Views | Article |
---|---|
Sickle Cell Disease, a Review
by
Cameron K. Tebbi
|
|
What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by
Marco Pizzi, Carmela Gurrieri and Attilio Orazi
|
|
Peripheral T-Cell Lymphomas of the T Follicular Helper Type: Clinical, Pathological, and Genetic Attributes
by
Karthik A. Ganapathi, Kristin H. Karner and Madhu P. Menon
|
|
Cold Agglutinin Disease: A Distinct Clonal B-Cell Lymphoproliferative Disorder of the Bone Marrow
by
Fina Climent, Joan Cid and Anna Sureda
|
|
Why Immunotherapy Fails in Multiple Myeloma
by
Luis Gerardo Rodríguez-Lobato, Aina Oliver-Caldés, David F. Moreno, Carlos Fernández de Larrea and Joan Bladé
|
|
Bing–Neel Syndrome: Update on Diagnosis and Treatment
by
Evangeline Y. Wong, Shirley D’Sa, Monique C. Minnema, Jorge J. Castillo and Dipti Talaulikar
|
|
Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
by
Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka and Josephine M. I. Vos
|
|
Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
by
Gareth J. Morgan, Joel N. Buxbaum and Jeffery W. Kelly
|
|
Pathophysiology of Myelodysplastic Syndromes
by
Michaela Fontenay, Batoul Farhat and Ismael Boussaid
|
|
Future Developments in the Treatment of AL Amyloidosis
by
Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos and Efstathios Kastritis
|
Downloads | Article |
---|---|
Sickle Cell Disease, a Review
by
Cameron K. Tebbi
|
|
Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes
by
Vincent Jachiet, Pierre Fenaux, Anna Sevoyan, Yervand Hakobyan, Lionel Ades, Olivier Fain, Arsène Mekinian and on behalf of the MINHEMON and GFM
|
|
Treatment of Lower Risk Myelodysplastic Syndromes
by
Valeria Santini
|
|
Future Developments in the Treatment of AL Amyloidosis
by
Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos and Efstathios Kastritis
|
|
Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?
by
Joana Caetano, Filipa Barahona, Paulo Lúcio and Cristina João
|
|
Current Status of CAR-T Cell Therapy in Multiple Myeloma
by
Juan Luis Reguera-Ortega, Estefanía García-Guerrero and Jose Antonio Pérez-Simón
|
|
SARS-CoV-2 and Autoimmune Cytopenia
by
Ryann Quinn and Irina Murakhovskaya
|
|
What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by
Marco Pizzi, Carmela Gurrieri and Attilio Orazi
|
|
Role and Modulation of NK Cells in Multiple Myeloma
by
Marie Thérèse Rubio, Adèle Dhuyser and Stéphanie Nguyen
|
|
Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies
by
Johannes P. M. van de Mortel, Shirley D’Sa, Alexander F. J. E. Vrancken, Nicolette C. Notermans, Josephine M. I. Vos and Monique C. Minnema
|
Downloads | Article |
---|---|
Mediastinal Gray-Zone Lymphoma: Still an Open Issue
by
Stefano Pileri, Valentina Tabanelli, Roberto Chiarle, Angelica Calleri, Federica Melle, Giovanna Motta, Maria Rosaria Sapienza, Elena Sabattini, Pier Luigi Zinzani and Enrico Derenzini
|
|
BTK Inhibitors and Other Targeted Therapies in Waldenström Macroglobulinemia
by
Karan L. Chohan and Prashant Kapoor
|
|
Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
by
Jessica Gill, Davide Stella, Irene Dogliotti, Chiara Dellacasa, Luisa Giaccone and Alessandro Busca
|
|
The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia
by
Alessandro Costa, Raimondo Pittorru, Giovanni Caocci, Federico Migliore, Francesco Tona, Olga Mulas and Giorgio La Nasa
|
|
The Role of Allogeneic Transplantation in Chronic Myeloid Leukemia in 2023: A Case-Based Concise Review
by
Mario Tiribelli, Giuseppe Petruzzellis, Giulia Battaglia, Martina Pucillo, Marta Lisa Battista, Michela Cerno, Antonella Geromin, Gabriele Facchin, Umberto Pizzano, Daniela Damiani, Renato Fanin and Francesca Patriarca
|
|
SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?
by
José Luis Piñana, Manuel Guerreiro and Carlos Solano
|
|
Renal Disorders Associated with Waldenström Macroglobulinaemia, IgM MGUS and IgM-Producing B-Cell Lymphoproliferative Disorders
by
Guy Pratt, Hannah V. Giles and Jennifer H. Pinney
|
|
IgM-Associated Cryoglobulinaemia
by
Jahanzaib Khwaja, Simon J. Salter and Shirley D’Sa
|
|
Efficacy of an Anticoagulation Clinic in Low-Income Brazilian Patients with Heart Disease: A Randomized Clinical Trial
by
Maria Auxiliadora Parreiras Martins, João Antonio de Queiroz Oliveira, Daniel Dias Ribeiro, Cibele Comini César, Vandack Alencar Nobre, Daniel Moore Freitas Palhares, Manoel Otávio da Costa Rocha and Antonio Luiz Pinho Ribeiro
|
|
MYD88 Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges
by
Tina Bagratuni, Alexandra Papadimou, Kostantina Taouxi, Meletios A. Dimopoulos and Efstathios Kastritis
|
Downloads | Article |
---|---|
The Role of Platelet Molecules in Risk Stratification of Patients with COVID-19
by
Lívia de Oliveira Sales, Lais Lacerda Brasil de Oliveira, Jean Breno Silveira da Silva, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro and Caroline Aquino Moreira-Nunes
|
|
Parenteral Iron Therapy for Pediatric Patients
by
Elpis Mantadakis, Sonia Alexiadou and Panagiota Zikidou
|
|
Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis
by
Michael Dennis Weaver, Bianca Glass, Chance Aplanalp, Gauri Patel, Jeshrine Mazhil, Isabella Wang and Samir Dalia
|
|
Coagulation Profiles in Humans Exposed to Exertional Hypobaric Decompression Stress Determined by Calibrated Automated Thrombogram
by
Leigh A. Madden, Rebecca V. Vince, Victoria C. Edwards, Vivienne M. Lee and Desmond M. Connolly
|
|
Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance
by
Karina P. Verma, Rebecca Steuer and Camille V. Edwards
|
|
Methotrexate-Induced Subacute Combined Degeneration in Acute Lymphoblastic Leukemia with CNS Relapse May Be Reversible
by
David Bared Dukenik, Deborah Soong, Wenhui Li, Ellen Madarang, Justin Watts and Justin Taylor
|
|
Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia
by
Francisco Alejandro Lagunas-Rangel and Venice Chávez-Valencia
|
|
Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations
by
Aditi Sharma, Amit Dahiya, Asif Alavi, Indryas Woldie, Aditya Sharma, Jeffrey Karson and Vijendra Singh
|
|
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis
by
Chiara Marvisi, Elena Galli, Caterina Ricordi, Rexhep Durmo, Massimo Roncali, Francesco Muratore, Carlo Salvarani and Annibale Versari
|
|
Fibril-Forming Organelles in Mesangial Cells in Renal Biopsies from Patients with Light-Chain-Associated Amyloidosis
by
Guillermo A. Herrera, Jiamin Teng, Chun Zeng, Luis Del Pozo-Yauner, Bing Liu and Elba A. Turbat-Herrera
|
Downloads | Article |
---|---|
Sickle Cell Disease, a Review
by
Cameron K. Tebbi
|
|
Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes
by
Vincent Jachiet, Pierre Fenaux, Anna Sevoyan, Yervand Hakobyan, Lionel Ades, Olivier Fain, Arsène Mekinian and on behalf of the MINHEMON and GFM
|
|
Why Immunotherapy Fails in Multiple Myeloma
by
Luis Gerardo Rodríguez-Lobato, Aina Oliver-Caldés, David F. Moreno, Carlos Fernández de Larrea and Joan Bladé
|
|
The Next Step for MRD in Myeloma? Treating MRD Relapse after First Line Treatment in the REMNANT Study
by
Anne-Marie Rasmussen, Frida Bugge Askeland and Fredrik Schjesvold
|
|
Treatment of Lower Risk Myelodysplastic Syndromes
by
Valeria Santini
|
|
Future Developments in the Treatment of AL Amyloidosis
by
Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos and Efstathios Kastritis
|
|
Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?
by
Joana Caetano, Filipa Barahona, Paulo Lúcio and Cristina João
|
|
The Management of Hematologic Patients with Bloodstream Infections Due to Multi-Drug Resistant Bacteria: Where Do We Stand? From Antibacterial Prophylaxis to the Treatment of Septic Shock
by
Carolina Secreto, Alessandro Busca, Tommaso Lupia, Silvia Corcione and Francesco Giuseppe De Rosa
|